Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors
- DOI
- 10.1177/17588359261423890
- Published
- 2026-02-27
- Container
- Therapeutic Advances in Medical Oncology
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/17588359261423890,
title = {Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors},
author = {Robert Hsu and Karen Resnick and Peter Zang and Travis Larsen and Shirley Ye and April Choi and Shawn Yu and Kevin Brady and Trevor E. Angell and Lily Dara and Fumito Ito and Jorge J. Nieva and Gino K. In},
year = {2026},
journal = {Therapeutic Advances in Medical Oncology},
doi = {10.1177/17588359261423890},
url = {https://doi.org/10.1177/17588359261423890}
}RIS
TY - JOUR TI - Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors AU - Robert Hsu AU - Karen Resnick AU - Peter Zang AU - Travis Larsen AU - Shirley Ye AU - April Choi AU - Shawn Yu AU - Kevin Brady AU - Trevor E. Angell AU - Lily Dara AU - Fumito Ito AU - Jorge J. Nieva AU - Gino K. In PY - 2026 JO - Therapeutic Advances in Medical Oncology DO - 10.1177/17588359261423890 UR - https://doi.org/10.1177/17588359261423890 ER -
APA
Hsu, R., Resnick, K., Zang, P., Larsen, T., Ye, S., Choi, A., Yu, S., Brady, K., Angell, T. E., Dara, L., Ito, F., Nieva, J. J., & In, G. K. (2026). Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology. https://doi.org/10.1177/17588359261423890
Source records
- crossref · retrieved 2026-09-26T23:52:54.745Z